Biomimetic nanoparticle delivery systems (e.g., CAF membrane‐coated liposomes) enable precise delivery of TGF‐β siRNA to the TME, achieving synergistic CAF reprogramming and cytokine suppression in breast cancer models. Here, TGFB1 is linked to breast cancer.